Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 03/20/2026 | CALL | $75.00 | 10 | +1 | +11.11% |
| 02/20/2026 | CALL | $50.00 | 0 | 0 | |
| 02/20/2026 | CALL | $55.00 | 0 | 0 | |
| 02/20/2026 | CALL | $60.00 | 0 | 0 | |
| 02/20/2026 | CALL | $65.00 | 0 | 0 | |
| 02/20/2026 | CALL | $70.00 | 20 | 0 | |
| 01/21/2028 | PUT | $95.00 | 0 | 0 | |
| 01/21/2028 | PUT | $100.00 | 0 | 0 | |
| 01/21/2028 | PUT | $105.00 | 0 | 0 | |
| 01/21/2028 | PUT | $110.00 | 0 | 0 | |
| 01/21/2028 | PUT | $115.00 | 0 | 0 | |
| 02/20/2026 | CALL | $75.00 | 141 | -1 | -0.70% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.96% | 2.18M | 87.61M |
| Vanguard Small-Cap Index Fund | 2.51% | 1.85M | 74.35M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.45% | 1.81M | 72.62M |
| Fidelity Select Portfolios - Biotechnology | 2.20% | 1.62M | 65.1M |
| iShares Russell 2000 ETF | 2.09% | 1.55M | 62.06M |
| Hartford Mid Cap Fund | 1.90% | 1.4M | 56.17M |
| Vanguard Specialized-Health Care Fund | 1.67% | 1.24M | 49.62M |
| Delaware Group Equity Fds V-Small Cap Core Fund | 1.48% | 1.1M | 43.98M |
| Vanguard Small-Cap Growth Index Fund | 1.45% | 1.07M | 42.97M |
| Vanguard Extended Market Index Fund | 1.32% | 976.77k | 39.22M |
What's Going On With Royalty Pharma Stock Wednesday?
12/31 11:47 am
Benzinga
Read moreRoyalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones
12/29 05:40 pm
Benzinga
Read moreNovartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
07/17 01:00 am
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
06/02 01:55 pm
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
06/02 01:52 pm
GlobeNewswire Inc.
Read moreRNA Targeting Small Molecule Drug Discovery Research Report 2025 - Global $5.52 Bn Market Trends, Opportunities, and Forecasts, 2020-2030F
05/29 10:56 am
GlobeNewswire Inc.
Read moreEvolving Landscape of Mitochondrial Disease Market: Key Insights of Latest Published Report—Leigh Syndrome, Leber’s Hereditary Optic Neuropathy, MELAS Syndrome, and Thymidine Kinase 2 Deficiency | DelveInsight
05/26 01:00 pm
GlobeNewswire Inc.
Read morePTC Therapeutics, Inc. (PTCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek ... - GlobeNewswire
07/09 02:01 pm
GlobeNewswire Inc.
Read morePTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
07/01 08:00 am
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?
06/24 04:44 am
Zacks Investment Research
Read moreThe Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
05/24 09:38 am
Zacks Investment Research
Read moreBiotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
05/23 12:46 pm
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
05/21 12:26 pm
Zacks Investment Research
Read moreCompared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics
04/25 08:00 pm
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04/18 10:01 am
Zacks Investment Research
Read moreBiotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
03/21 10:01 am
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Up on Positive Regulatory Updates
03/20 02:00 pm
Zacks Investment Research
Read moreCooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
03/01 12:18 pm
Benzinga
Read moreHere's What Key Metrics Tell Us About PTC Therapeutics (PTCT) Q4 Earnings
02/29 07:00 pm
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Reports Q4 Loss, Lags Revenue Estimates
02/29 06:20 pm
Zacks Investment Research
Read moreWall Street's Insights Into Key Metrics Ahead of PTC Therapeutics (PTCT) Q4 Earnings
02/26 10:16 am
Zacks Investment Research
Read moreWill Karyopharm Therapeutics (KPTI) Report Negative Q4 Earnings? What You Should Know
02/14 11:00 am
Zacks Investment Research
Read morePTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth
02/13 11:00 am
Zacks Investment Research
Read more1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
02/11 02:45 am
The Motley Fool
Read moreStrength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?
01/05 04:09 am
Zacks Investment Research
Read moreBiogen's (BIIB) Rare Disease Drug Skyclarys Gets CHMP Nod in EU
12/18 10:57 am
Zacks Investment Research
Read moreSolid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up
12/08 06:37 am
Zacks Investment Research
Read moreEntrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug
11/23 12:47 pm
Zacks Investment Research
Read moreAnalyst Expectations for PTC Therapeutics's Future
11/20 11:00 am
Benzinga
Read moreSolid Biosciences (SLDB) Stock Up as FDA Clears DMD Drug IND
11/16 09:29 am
Zacks Investment Research
Read morePinterest Primed for Rich Ad Spend; Adobe a Powerhouse: Street Calls of the Week
10/29 09:46 am
Investing.com
Read moreAmazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday
10/27 08:06 am
Benzinga
Read moreThe Zacks Analyst Blog Highlights Bristol Myers, PTC Therapeutics, Beam Therapeutics and BioMarin Pharmaceutical
10/27 07:15 am
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10/26 07:30 pm
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Reports Q3 Loss, Lags Revenue Estimates
10/26 05:30 pm
Zacks Investment Research
Read moreBiotech Stock Roundup: BMY's Q3 Results, PTCT Up on Deal, BEAM's Restructuring News
10/26 11:28 am
Zacks Investment Research
Read moreNeurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
10/24 10:00 am
Zacks Investment Research
Read moreWhy PTC Therapeutics Soared 15% Higher Today
10/19 07:02 pm
The Motley Fool
Read moreNasdaq Falls 100 Points; AT&T Posts Upbeat Earnings
10/19 02:37 pm
Benzinga
Read morePTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
10/19 10:01 am
Zacks Investment Research
Read moreAT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday
10/19 09:56 am
Benzinga
Read morePTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion
10/19 09:18 am
MarketWatch
Read morePTC Therapeutics (PTCT) Moves 5.3% Higher: Will This Strength Last?
10/11 08:07 am
Zacks Investment Research
Read moreBenzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
10/06 11:00 am
Benzinga
Read morePTC Therapeutics (PTCT) to Cut 25% Jobs by January 2024
09/29 11:18 am
Zacks Investment Research
Read moreBiotech Stock Roundup: GSK's Drug Approval, MRNA's Vaccine News, PTCT & SPRY Down
09/21 10:43 am
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Surges 5.8%: Is This an Indication of Further Gains?
09/20 04:00 am
Zacks Investment Research
Read more